UBS Group »

Xilio Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Xilio Therapeutics

Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 20250100k200k0100k200k
Value ($)Share countHistorical XLO position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $238k 249k 0.96
2024-09-30 $12k 16k 0.79
2024-06-30 $190 201 0.95
2024-03-31 $216 201 1.08
2023-12-31 $110 201 0.55
2023-09-30 $424 201 2.11
2023-06-30 $527 201 2.62
2023-03-31 $637 201 3.17
2022-12-31 $540 201 2.69
2022-09-30 $999 201 4.98
2022-06-30 $14k 2.8k 4.98
2022-03-31 $7.0k 964 7.26
2021-12-31 $64k 4.0k 16.09